Revenue missed analyst estimates by 2.3%. Earnings per share (EPS) exceeded analyst estimates by 4.9%. Looking ahead, revenue is forecast to grow 28% p.a. on average during the next 3 years, compared ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the electroCore Third Quarter 2024 ...

Maxim Group analyst Anthony Vendetti has reiterated their bullish stance on ECOR stock, giving a Buy rating yesterday. Anthony Vendetti has ...

Electrocore (ECOR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Swayampakula ...

Despite achieving its eighth consecutive record revenue quarter, electroCore Inc (ECOR) faces hurdles with net losses and ...

For the quarter ended September 30, 2024, electroCore reported net sales of $6.6 million compared to $4.5 million during the same period of 2023, which represents an approximate 45% increase over the ...

ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness ...

ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness ...

Greetings, and welcome to the electroCore Third Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce ...

For the quarter ended September 30, 2024, electroCore reported net sales of $6.6 million compared to $4.5 million during the same period of 2023, which represents an approximate 45% increase over ...